Back to results
US 7,598,263 B2Granted
Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
AssigneeBayer Schering Pharma Aktiengesellschaft
InventorsOlaf Prien, Knut Eis, Wolfgang Schwede, Judith Guenther, Dieter Zopf
Life of this patent
Estimating the term…
Abstract
The present invention relates to a quinoline derivative having the general formula (A): in which R1, R2, X, Y and Z are indicated in the description and the claims, the use of the compounds of the general formula (A) for the treatment of various disorders, and the preparation of compounds of the general formula (A).
Claims17
A quinoline compound of formula (A):
- wherein
- R1 and R2 are identical or different and are each, independently of one another, hydrogen, hydroxy, halogen, nitro, cyano, —C1-C6-alkyl, —C1-C4-hydroxyalkyl, —C2-C6-alkenyl, —C2-C6-alkynyl, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, —C6-C12-aryl, —C5-C18-heteroaryl, —C1-C6-alkoxy, —C1-C6-alkoxy-C1-C6-alkoxy, —C1-C6-alkoxy-C1-C6-alkyl, —C1-C6-alkoxy-C1-C6-alkoxy-C1-C6-alkyl, —(CH2)n—C6-C12-aryl, —(CH2)n—C5-C18-heteroaryl, —(CH2)n—C3-C10-cycloalkyl, —(CH2)n—C3-C12-heterocycloalkyl, -phenylene-(CH2)p—R6, —(CH2)pPO3(R6)2, —(CH2)p—NR5R6, —(CH2)p—NR4COR5, —(CH2)p—NR4CSR5, —(CH2)p—NR4S(O)R5, —(CH2)p—NR4S(O)2R5, —(CH2)p—NR4CONR5R6, —(CH2)p—NR4COOR5, —(CH2)p—NR4C(NH)NR5R6, —(CH2)p—NR4CSNR5R6, —(CH2)p—NR5(O)NR5R6, —(CH2)p—NR4S(O)2NR5R6, —(CH2)p—COR5, —(CH2)p—CSR5, —(CH2)p—S(O)R5, —(CH2)p—S(O)(NH)R5, —(CH2)p—S(O)2R5, —(CH2)p—S(O)2NR5R6, —(CH2)p—SO2OR5, —(CH2)p—CO2R5, —(CH2)p—CONR5R6, —(CH2)p—CSNR5R6, —OR5, —CHR5R6, —(CH2)p—SR5, or —CR5(OH)—R6,
- where —C1-C6-alkyl, —C2-C6-alkenyl, —C2-C6-alkynyl, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, —C6-C12-aryl, —C5-C18-heteroaryl, and —C1-C6-alkoxy are in each case unsubstituted or substituted one or more times independently of one another by hydroxy, halogen, nitro, cyano, —NR5R6, —C(O)NR5R6, —S(O)2NR5R6, —NR5S(O)2R6, —NR5C(O)R6, —SR5, —R5, or —OR5,
- where the carbon framework of the —C3-C10-cycloalkyl and of the —C1-C10-alkyl groups optionally include, independently of one another, one or more nitrogen atoms, oxygen atoms, sulphur atoms, —NR4 groups, or C═O groups, or optionally include one or more double bonds, and
- where the phenyl radical is optionally substituted one or more times independently of one another by hydroxy, halogen, nitro, cyano, phenyl, —NR5R6, alkyl or —OR5;
- or
- R1 and R2 form together a bridge of 3-10 methylene units, where up to two methylene units are each optionally replaced by O, S or —NR4;
- X, Y, Z are identical or different and are each, independently of one another, —CR3═, —CR3R4—, —C(O)—, —N═, —S—, —O—, —NR3—, —S(O)2—, —S(O)—, or —S(O)(N═R3)—, and single or double bonds are present between X, Y and Z, wherein a maximum of one of X, Y and Z is —O—, and at most one of X, Y and Z is —N═ or —NR3—;
- R3 and R4 are each, independently of one another, hydrogen, —C1-C10-alkyl, —C2-C6-alkenyl, —C2-C6-alkynyl, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, or —C1-C10-alkanoyl,
- where —C1-C10-alkyl, —C2-C6-alkenyl, —C2-C6-alkynyl, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, and —C1-C10-alkanoyl are in each case, independently of one another, unsubstituted or substituted one or more times by hydroxy, halogen, nitro, cyano, phenyl, —NR5R6, alkyl, —SR5, or —OR5,
- R5 and R6 are identical or different and are each, independently of one another, hydrogen, —C1-C10-alkyl, —C2-C10-alkenyl, —C2-C10-alkynyl, —C1-C6-alkoxy, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, —C6-C12-aryl, or —C5-C18-heteroaryl,
- where —C1-C10-alkyl, —C2-C10-alkenyl, —C2-C10-alkynyl, —C1-C6-alkoxy, —C3-C10-cycloalkyl, —C3-C12-heterocycloalkyl, —C6-C12-aryl, and —C5-C18-heteroaryl are in each case, independently of one another, unsubstituted or substituted one or more times by hydroxy, halogen, cyano, nitro, —OR7, —NR7R8, —C(O)NR7R8, —C(O)OR7, or —C1-C6-alkyl,
- where —C1-C6-alkyl is unsubstituted or is substituted one or more times independently of one another by halogen, hydroxy, cyano, —NR7R8, —OR7 or phenyl;
- or
- R5 and R6 together form a bridge of 3-10 methylene units, where up to two methylene units are each optionally replaced by O, S or NR4;
- R7 and R8 are identical or different and are each, independently of one another, hydrogen, —C1-C4-alkyl, —C6-C12-aryl, or —C5-C18-heteroaryl,
- where alkyl, aryl, and heteroaryl are each, independently of one another, unsubstituted or substituted one or more times by halogen or alkoxy, or
- R7 and R8 together form a bridge of 3-10 methylene units, where up to two methylene units are each optionally replaced by O, S or —NR4;
- m′, m″ are independently of one another 0, 1, 2, 3, or 4,
- n is 1, 2, 3, 4, 5, or 6, and
- p is 0, 1, 2, 3, 4, 5, or 6;
- or
- an N-oxide, stereoisomer, diastereomer, enantiomer or salt thereof.
20 more elements
Dependencies are inferred from the claim text.